M J Abzug

Summary

Affiliation: University of Colorado
Country: USA

Publications

  1. ncbi Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children
    Mark J Abzug
    University of Colorado School of Medicine and The Children s Hospital Pediatric Infectious Diseases, Department of Pediatrics, Denver, CO 80218, USA
    Pediatr Infect Dis J 23:769-73. 2004
  2. ncbi Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy
    Mark J Abzug
    University of Colorado Denver School of Medicine and The Children s Hospital, 13123 E 16th Avenue, Aurora, CO 80045, USA
    J Infect Dis 200:935-46. 2009
  3. ncbi Protection of murine gestational tissues from picornavirus infection in the preimplantation period
    M J Abzug
    Department of Pediatrics Infectious Diseases and Pathology, University of Colorado School of Medicine and The Children s Hospital, USA
    Placenta 21:422-6. 2000
  4. ncbi Establishment of a clinical trials office at a children's hospital
    M J Abzug
    Children s Hospital and Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado 80218, USA
    Pediatrics 108:1129-34. 2001
  5. ncbi The enteroviruses: an emerging infectious disease? The real, the speculative and the really speculative
    Mark J Abzug
    Department of Pediatrics, Pediatric Infectious Diseases, University of Colorado School of Medicine, The Children s Hospital, Denver, CO 80218, USA
    Adv Exp Med Biol 609:1-15. 2008
  6. ncbi Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis
    Mark J Abzug
    Pediatric Infectious Disease, Department of Pediatrics, University of Colorado School of Medicine and The Children s Hospital, 1056 E Nineteenth Avenue, Denver, CO 80218, USA
    Pediatr Infect Dis J 22:335-41. 2003
  7. ncbi Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy
    Mark J Abzug
    School of Medicine, University of Colorado and Children s Hospital, Denver, Colorado, USA
    Pediatrics 120:e1190-202. 2007
  8. ncbi Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy
    Mark J Abzug
    University of Colorado School of Medicine, Pediatric Infectious Disease, The Children s Hospital, Denver, CO 80218, USA
    Pediatr Infect Dis J 25:920-9. 2006
  9. ncbi Evolution of the placental barrier to fetal infection by murine enteroviruses
    M J Abzug
    Department of Pediatrics Section of Infectious Diseases, University of Colorado School of Medicine, Denver
    J Infect Dis 163:1336-41. 1991
  10. ncbi Prognosis for neonates with enterovirus hepatitis and coagulopathy
    M J Abzug
    The Children s Hospital, Denver, CO 80218, USA
    Pediatr Infect Dis J 20:758-63. 2001

Detail Information

Publications17

  1. ncbi Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children
    Mark J Abzug
    University of Colorado School of Medicine and The Children s Hospital Pediatric Infectious Diseases, Department of Pediatrics, Denver, CO 80218, USA
    Pediatr Infect Dis J 23:769-73. 2004
    ..Adjunctive therapy with interferon-gamma, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor can be considered for refractory invasive fungal infections...
  2. ncbi Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy
    Mark J Abzug
    University of Colorado Denver School of Medicine and The Children s Hospital, 13123 E 16th Avenue, Aurora, CO 80045, USA
    J Infect Dis 200:935-46. 2009
    ..The immunogenicity of HBV vaccination in children receiving highly active antiretroviral therapy (HAART) was investigated...
  3. ncbi Protection of murine gestational tissues from picornavirus infection in the preimplantation period
    M J Abzug
    Department of Pediatrics Infectious Diseases and Pathology, University of Colorado School of Medicine and The Children s Hospital, USA
    Placenta 21:422-6. 2000
    ..These results indicate that gestational tissues are largely protected from viral infection before implantation. After implantation, gestational tissues are more readily infected and damaged by maternal picornavirus infection...
  4. ncbi Establishment of a clinical trials office at a children's hospital
    M J Abzug
    Children s Hospital and Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado 80218, USA
    Pediatrics 108:1129-34. 2001
    ..To create a clinical trials office (CTO) at a children's hospital and assess its impact...
  5. ncbi The enteroviruses: an emerging infectious disease? The real, the speculative and the really speculative
    Mark J Abzug
    Department of Pediatrics, Pediatric Infectious Diseases, University of Colorado School of Medicine, The Children s Hospital, Denver, CO 80218, USA
    Adv Exp Med Biol 609:1-15. 2008
  6. ncbi Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis
    Mark J Abzug
    Pediatric Infectious Disease, Department of Pediatrics, University of Colorado School of Medicine and The Children s Hospital, 1056 E Nineteenth Avenue, Denver, CO 80218, USA
    Pediatr Infect Dis J 22:335-41. 2003
    ..Treatment of older children and adults with pleconaril has been associated with reduced severity and duration of symptoms. This study evaluated the pharmacokinetics, safety and efficacy of pleconaril in infants with EV meningitis...
  7. ncbi Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy
    Mark J Abzug
    School of Medicine, University of Colorado and Children s Hospital, Denver, Colorado, USA
    Pediatrics 120:e1190-202. 2007
    ..Our goal was to evaluate the immunogenicity and safety of pertussis booster vaccination in children infected with HIV on highly active antiretroviral therapy (HAART)...
  8. ncbi Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy
    Mark J Abzug
    University of Colorado School of Medicine, Pediatric Infectious Disease, The Children s Hospital, Denver, CO 80218, USA
    Pediatr Infect Dis J 25:920-9. 2006
    ....
  9. ncbi Evolution of the placental barrier to fetal infection by murine enteroviruses
    M J Abzug
    Department of Pediatrics Section of Infectious Diseases, University of Colorado School of Medicine, Denver
    J Infect Dis 163:1336-41. 1991
    ..The placental barrier to enterovirus transmission appears to develop between early and middle gestation. Enterovirus infection before this time may induce placental damage, fetal infection, or both...
  10. ncbi Prognosis for neonates with enterovirus hepatitis and coagulopathy
    M J Abzug
    The Children s Hospital, Denver, CO 80218, USA
    Pediatr Infect Dis J 20:758-63. 2001
    ..Neonatal enterovirus hepatitis and coagulopathy (EHC) can be a severe, life-threatening infection. However, the case-fatality rate of EHC and the prognosis for survivors are not well-defined...
  11. ncbi Chronic rhinosinusitis in young children differs from adults: a histopathology study
    Kenny H Chan
    Departments of Otolaryngology Head and Neck Surgery, University of Colorado School of Medicine, The Children s Hospital, Denver, Colorado 80218, USA
    J Pediatr 144:206-12. 2004
    ..A histopathologic study of children with chronic rhinosinusitis (CRS) was undertaken to compare the sinus mucosa in pediatric and adult CRS...
  12. ncbi Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature
    Jill H Simmons
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO, USA
    Pediatr Diabetes 6:234-8. 2005
    ..To illustrate that rapid diagnosis and aggressive treatment of rhinocerebral mucormycosis with internal carotid artery occlusion in a pediatric patient can prevent mortality and significant morbidity...
  13. ncbi Presentation, diagnosis, and management of enterovirus infections in neonates
    Mark J Abzug
    Department of Pediatrics, Pediatric Infectious Diseases, University of Colorado School of Medicine and The Children's Hospital, Denver, Colorado 80218, USA
    Paediatr Drugs 6:1-10. 2004
    ..Limited pharmacokinetic data are available in infants and neonates. A multicenter, placebo-controlled, randomized trial of pleconaril in neonates with severe hepatitis, coagulopathy, and/or myocarditis is currently being conducted...
  14. ncbi Identification of trophoblastic giant cells as the initial principal target of early gestational murine enterovirus infection
    M J Abzug
    Department of Pediatrics Section of Infectious Diseases, Children s Hospital, Denver, Colorado
    Placenta 14:137-48. 1993
    ..Giant cells are the earliest predominant target of TMEV infection following early gestation inoculation and appear to be an integral part of the pathogenesis of gestational murine enterovirus infection...
  15. ncbi Human herpesviruses 6 and 7 and central nervous system infection in children
    Asad Ansari
    University of Colorado School of Medicine, Denver, Colorado 90262, USA
    Emerg Infect Dis 10:1450-4. 2004
    ..HHV-6 was likely pathogenic in two patients with meningitis who lacked evidence of another microbiologic cause. HHV-6 and HHV-7 are uncommon causes of CNS infection in children. HHV-6 may occasionally cause meningitis in young infants...
  16. ncbi Safety of oseltamivir compared with the adamantanes in children less than 12 months of age
    David W Kimberlin
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Alabama, Birmingham, Birmingham, AL 35233, USA
    Pediatr Infect Dis J 29:195-8. 2010
    ..To assess potential neurologic adverse effects of oseltamivir use in infants, a retrospective chart review was performed in infants less than 12 months of age who received oseltamivir, amantadine, or rimantadine...
  17. ncbi In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children
    Susan B Brogly
    Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    AIDS 21:929-38. 2007
    ..There is equivocal evidence of in utero nucleoside reverse transcriptase inhibitor (NRTI) exposure and the occurrence of mitochondrial dysfunction (MD) in HIV-uninfected children born of HIV-infected women...